Catalyst Wire Dossier Catalyst Wire Dossier

GNS-212-E

· Gunkang Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNS-212-E, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy [Phase 3]

See pricing